Pathology and diagnosis of renal non-AL amyloidosis

被引:0
|
作者
Sanjeev Sethi
Jason D. Theis
机构
[1] Mayo Clinic,Department of Laboratory Medicine and Pathology
来源
Journal of Nephrology | 2018年 / 31卷
关键词
Amyloid; ALECT2; Apolipoproteins; Fibrinogen alpha; Gelsolin; Laser-microdissection; Mass spectrometry;
D O I
暂无
中图分类号
学科分类号
摘要
Renal amyloidosis is characterized by acellular Congo red positive deposits in the glomeruli, interstitium and/or arteries. Light chain restriction on immunofluorescence studies is present in AL-amyloidosis, the most common type of amyloidosis involving the kidney. The detection of Congo red positive deposits coupled with negative immunofluorescence studies is highly suggestive of non-AL amyloidosis. Some of the non-AL amyloidosis are common while others are relatively rare. The clinical features, laboratory and renal pathology findings are helpful in the diagnosis and typing of non-AL amyloidosis. Thus, ALECT2 amyloidosis is characterized by diffuse cortical interstitial amyloid deposits, AA amyloidosis shows vascular deposits in addition to the glomerular deposits, AFib amyloidosis is characterized by massive amyloid accumulation limited to the glomeruli resulting in the obliteration of glomerular architecture, AApoA1 and AApoAIV are characterized by large amyloid deposits restricted to the medulla, and AGel shows swirling patterns of amyloid fibrils on electron microscopy. While light microscopy is very helpful, accurate typing of non-AL amyloidosis then requires immunohistochemical or laser microdissection/mass spectrometry studies of the Congo red positive deposits. Immunohistochemical studies are available for some of the non-AL amyloidosis. On the other hand, mass spectrometry analysis is a one stop methodology for confirmation and typing of amyloidosis. The diagnosis and typing of amyloidosis by mass spectrometry is based on finding the signature amyloid peptides, apolipoprotein E and serum amyloid-P component, followed by detection of precursor amyloidogenic protein such as LECT2, fibrinogen-α, gelsolin, etc. To, summarize, non-AL amyloidosis is a group of amyloidosis with distinctive clinical, laboratory and renal pathology findings. Typing of the amyloidosis is best performed using mass spectrometry methodology. Accurate typing of non-AL amyloidosis is imperative for correct management, prognosis, and genetic counseling.
引用
收藏
页码:343 / 350
页数:7
相关论文
共 50 条
  • [1] Pathology and diagnosis of renal non-AL amyloidosis
    Sethi, Sanjeev
    Theis, Jason D.
    JOURNAL OF NEPHROLOGY, 2018, 31 (03) : 343 - 350
  • [2] AJKD Atlas of Renal Pathology: Hereditary and Other Non-AL Amyloidoses
    Fogo, Agnes B.
    Lusco, Mark A.
    Najafian, Behzad
    Alpers, Charles E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (06) : E49 - E51
  • [3] Autologous hematopoietic stem cell transplantation for non-AL amyloidosis monoclonal gammopathy of renal significance
    Liu, Mengnan
    Zhao, Liang
    Guo, Jinzhou
    Chen, Wencui
    Wu, Xiaomei
    Xu, Weiwei
    Huang, Xianghua
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025,
  • [4] Renal biopsy is a relatively safe procedure in cases of suspected amyloidosis and a valuable tool in excluding non-AL forms of the disease
    Gibbs, S. D. J.
    Sattianayagam, P. T.
    Pinney, J. H.
    Gilbertson, J. A.
    Lachmann, H. J.
    Wechalekar, A. D.
    Hawkins, P. N.
    Gillmore, J. D.
    INTERNAL MEDICINE JOURNAL, 2010, 40 (02) : 167 - 168
  • [5] AJKD Atlas of Renal Pathology: AL Amyloidosis
    Fogo, Agnes B.
    Lusco, Mark A.
    Najafian, Behzad
    Alpers, Charles E.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (06) : E43 - E45
  • [6] Immunoglobulin light and heavy chain amyloidosis AL/AH: Renal pathology and differential diagnosis
    Picken, Maria M.
    KIDNEY IN PLASMA CELL DYSCRASIAS, 2007, 153 : 135 - 155
  • [7] Experience with 84 cases of bone marrow amyloidosis - caution advised as deposits are frequently extramedullary and may be associated with non-AL amyloidosis
    Picken, M.
    VIRCHOWS ARCHIV, 2019, 475 : S335 - S336
  • [8] RENAL PATHOLOGY IN AMYLOIDOSIS
    TORNROTH, T
    FALCK, HM
    WEGELIUS, O
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1985, : 9 - 21
  • [9] Outcomes of non-AL monoclonal gammopathies of renal significance with clone-directed therapy
    Rubinstein, Samuel
    Peters, Daniel
    Lichtman, Eben
    Chakraborty, Rajshekhar
    Lentzsch, Suzanne
    Bhutani, Divaya
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S118 - S118
  • [10] Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management
    Shafqat, Areez
    Elmaleh, Hassan
    Mushtaq, Ali
    Firdous, Zaina
    Ashruf, Omer
    Mukhopadhyay, Debduti
    Ahmad, Maheen
    Ahmad, Mahnoor
    Raza, Shahzad
    Anwer, Faiz
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)